Clinical trial
Efficacy and Safety of Valsartan and the Combination of Valsartan and…
NCT00385931 · Novartis, Industry · Completed
Key facts
| NCT number | NCT00385931 |
|---|---|
| Title | Efficacy and Safety of Valsartan and the Combination of Valsartan and Simvastatin |
| Official title | A Multi-centre Study to Evaluate the Effects of Valsartan and the Combination of Valsartan and Simvastatin on Blood Pressure (Ambulatory and Std Cuff) and on Biochemical Markers of Endothelial Function (hsCRP, MCP-1, Serum F2 Isoprostanes, PAI-1, tPA, PICP, PIIINP, MMP9, MMP1, TIMP 1), Safety and… |
| Lead sponsor | Novartis, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hypertension, Hypercholesterolemia, Dyslipidemia |
| Intervention type | Drug |
| Interventions | Valsartan and simvastatin |
| Enrollment | 412 |
| Start date | Jan 1, 2002 |
| Primary completion | Apr 1, 2003 |
| Completion | Apr 1, 2003 |
| First posted | Oct 11, 2006 |
| Last update posted | Nov 9, 2023 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: